Evidence map›Paper›PMID 30877378›Full record

ArticleLangenbeck's archives of surgery2019

Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA.

Patrick Mayr, Bruno Märkl, Abbas Agaimy, Bernadette Kriening, Sebastian Dintner, Gerhard Schenkirsch, Regine Schneider-Stock

Abstract read
PubMed Publisher
In one paragraph

Article in Langenbeck's archives of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. New C3H KitScientific reports · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Patrick MayrInstitute of Pathology, Klinikum Augsburg, Augsburg, Germany.
Bruno MärklInstitute of Pathology, Klinikum Augsburg, Augsburg, Germany. bruno.maerkl@uk-augsburg.de.ORCID http://orcid.org/0000-0002-7704-850X
Abbas AgaimyDepartment of Pathology, FAU Erlangen-Nürnberg, Erlangen, Germany.
Bernadette KrieningDepartment of Visceral Surgery, Klinikum Augsburg, Augsburg, Germany.
Sebastian DintnerInstitute of Pathology, Klinikum Augsburg, Augsburg, Germany.
Gerhard SchenkirschClinical and Population-Based Cancer Registry of Augsburg, Klinikum Augsburg, Augsburg, Germany.
Regine Schneider-StockDepartment of Pathology, FAU Erlangen-Nürnberg, Erlangen, Germany.
University Hospital Augsburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGastrointestinal stromal tumors (GISTs) are the most common soft tissue tumors of the GI tract. Studies have been published reporting additional neoplasms in GIST patients. This study aimed to evaluate possible associations of mutation type, morphology, and clinical aspects of GISTs.

methodsAll cases of GIST were identified from our pathology files. Coding exons of KIT and PDGFRA in GISTs with additional malignancies were sequenced.

resultsA total of 70 of 188 (37%) retrieved patients with confirmed diagnosis of GIST showed at least one additional malignant neoplasm. Fifty of these GISTs were located in the stomach (71%), 8 in the small intestine (11%), 5 in the colon/rectum (7%), and 7 cases (6.2%) were of undetermined sites of origin. The distribution of identified mutations was similar to that described in GISTs without secondary malignancies. A total of 37 of 57 cases (65%) showed mutations in the KIT gene exon 11, 3 (5%) cases in exon 9, and 1 (2%) case in exon 13. Nine tumors (16%) had mutations of the PDGFRA gene. KIT and PDGFRA wild-type status were found in seven cases (12%). Most of the secondary neoplasms were located within the GI tract (34%), in the urogenital system (24%), or the breast/female genital tract (20%).

conclusionThis study confirms the high rate of additional malignant tumors in GIST patients. GIST features in these cases are very similar to those with sole GIST.

Indexed as

AgedAged, 80 and overFemaleGastrointestinal NeoplasmsGastrointestinal Stromal TumorsHumansMaleMiddle AgedMutationNeoplasms, Second PrimaryProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaRetrospective StudiesKIT protein, humanProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaAdditional/secondary malignancyGastrointestinal stromal tumorGISTKITMutationPDGFRA

Identifiers

PMID30877378
OpenAlexW2921844501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.